Clinical Trial: Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures

Brief Summary: The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.

Detailed Summary:
Sponsor: Pfizer

Current Primary Outcome: Safety assessments are performed at quarterly visits up until the study is closed.

Original Primary Outcome: Same as current

Current Secondary Outcome: Seizure frequency is assessed throughout the study until the study is closed.

Original Secondary Outcome: Same as current

Information By: Pfizer

Dates:
Date Received: August 30, 2005
Date Started: September 2001
Date Completion: February 2006
Last Updated: July 21, 2006
Last Verified: March 2006